BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.120
+0.010 (0.90%)
Sep 3, 2026, 9:30 AM EDT - Market open

BioCardia Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--0.060.481.351.02
Revenue Growth
---87.84%-64.72%33.20%600.00%
Gross Profit
-4.19-4.96-4.33-7.25-7.48-7.54
Operating Income
-7.39-8.28-8-11.64-11.9-12.63
Net Income
-7.34-8.23-7.95-11.57-11.91-12.62
Earnings Per Share
-0.74-1.23-2.90-8.19-10.08-11.19
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4.122.52.371.17.3612.87
Total Debt
0.290.530.951.321.631.87
Net Cash (Debt)
3.821.971.42-0.215.7311
Net Cash Growth
1527.23%38.59%---47.91%-47.08%
Net Cash Per Share
0.380.300.52-0.154.859.76

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-7.56-7.44-7.89-9.97-10.56-10.37
Capital Expenditures
-0.01-0.01-0.01-0.01-0.07-0.12
Free Cash Flow
-7.57-7.44-7.89-9.99-10.63-10.48
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
---13794.83%-2441.09%-880.25%-1244.34%
Pretax Margin
---13700.00%-2425.79%-880.70%-1243.65%
Profit Margin
---13700.00%-2425.79%-880.70%-1243.64%
FCF Margin
---13606.90%-2093.50%-786.32%-1032.71%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--172.3132.8930.9932.25